Oscar Health (OSCR)
(Delayed Data from NYSE)
$15.25 USD
+0.29 (1.94%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $15.24 -0.01 (-0.07%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OSCR 15.25 +0.29(1.94%)
Will OSCR be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for OSCR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OSCR
Is SPDR S&P Insurance ETF (KIE) a Strong ETF Right Now?
Oscar Health, Inc. (OSCR) Exceeds Market Returns: Some Facts to Consider
OSCR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Oscar Health, Inc. (OSCR) Ascends While Market Falls: Some Facts to Note
Is Oscar Health (OSCR) Outperforming Other Finance Stocks This Year?
Is First Trust Small Cap Core AlphaDEX ETF (FYX) a Strong ETF Right Now?
Other News for OSCR
Oscar Health, Inc. 2024 Second Quarter Conference Call
Oscar Health falls -6.8%
Expert Ratings For Oscar Health
Duolingo appoints Schlosser as independent board member
3 Tantalizing Tech Stocks Ready to Make Millionaires in 2026